21 Oct ACG 2022 Annual Scientific Meeting, Charlotte, North Carolina

ASX:RHT

News

FerriScan® is now available on 3T MRI scanners!

Resonance Health Ltd announces the development of its newest AI medical device, LiverSmart, which is now undergoing final quality and verification checks prior to its submission to the United States Food & Drug Administration (FDA) for regulatory clearance.

LiverSmart combines two existing regulatory-cleared Resonance Health products, FerriSmart® and HepaFat-AI®, into a single multi-parametric MRI session, avoiding the need for multiple MRI appointments, and delivering a more complete and comprehensive assessment of a person’s liver.

Introducing Liversmart: A New Ai Medical Device

Resonance Health Ltd announces the development of its newest AI medical device, LiverSmart, which is now undergoing final quality and verification checks prior to its submission to the United States Food & Drug Administration (FDA) for regulatory clearance.

LiverSmart combines two existing regulatory-cleared Resonance Health products, FerriSmart® and HepaFat-AI®, into a single multi-parametric MRI session, avoiding the need for multiple MRI appointments, and delivering a more complete and comprehensive assessment of a person’s liver.

Introducing LiverSmart: A New AI Medical Device

Resonance Health Ltd announces the development of its newest AI medical device, LiverSmart, which is now undergoing final quality and verification checks prior to its submission to the United States Food & Drug Administration (FDA) for regulatory clearance. LiverSmart combines two existing regulatory-cleared Resonance Health products, FerriSmart® and HepaFat-AI®, into a single multi-parametric MRI session, …

Introducing LiverSmart: A New AI Medical Device Read More »

Resonance Health News – June 2021

Burjeel Medical City opens Thalassemia Center to help children with Thalassemia

VPS Healthcare’s premium medical facility, Burjeel Medical City at Mohammed Bin Zayed City, Abu Dhabi, has opened a Thalassemia Center to offer exclusive treatment for children diagnosed with the illness.